| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2347474C Bicyclic nitrogen heterocycles |
| 08/26/2008 | CA2239780C A process for regulating vagal tone |
| 08/21/2008 | WO2008101052A2 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract |
| 08/21/2008 | WO2008100912A1 Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| 08/21/2008 | WO2008100628A2 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 08/21/2008 | WO2008100480A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008100202A1 A 2-f luorobenzoate salt and a 2, 6-dif luorobenzoate salt of n-{5-chloro-2- [ ( (2s) -3-{ [1- (4-chlorobenzyl)piperidin-4- yl ] amino } - 2 - hydroxy- 2 -me t hylpr opyl ) oxy] - 4 - hydroxyphenyl } acetamide |
| 08/21/2008 | WO2008099920A1 Therapeutic agent for interstitial pulmonary disease comprising anti-hmgb-1 antibody |
| 08/21/2008 | WO2008099186A1 Heterocyclic derivatives as m3 muscarinic receptors |
| 08/21/2008 | WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases |
| 08/21/2008 | WO2008076269A3 MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS |
| 08/21/2008 | WO2008025787A3 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 08/21/2008 | US20080200566 Dephosphorylation of HDAC7 By Myosin Phosphatase |
| 08/21/2008 | US20080200494 Imidazopyridine Derivatives |
| 08/21/2008 | US20080200483 Purine Derivatives for Use as Adenosin A-2A Receptor Agonists |
| 08/21/2008 | US20080200476 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 08/21/2008 | US20080200467 alpha keto amides and alpha hydroxy amides; N-[3-(3-Morpholin-4-yl-propoxy)-phenyl]-2-oxo-2-(4-trifluoromethyl-phenyl)-acetamide; N-Adamantan-1-yl-2-(3-benzyloxyphenyl)-2-hydroxy-acetamide; hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases |
| 08/21/2008 | US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine |
| 08/21/2008 | US20080200454 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | US20080200449 For treating pulmonary hypertension; device can provide patients with a high degree of autonomy |
| 08/21/2008 | US20080200442 Use of fluoroquinolone antibiotic such as 1-cyclopropyl-8-chloro-6-fluoro-1,4-dihydro-7-(3-aminoazepan-1-yl)-4-oxo-3-quinolinecarboxylic acid; treating antibiotic resistant infections |
| 08/21/2008 | US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 08/21/2008 | US20080200394 Treatment of Inflammatory Airway Disease |
| 08/21/2008 | US20080199532 Congestive heart failure; induce vasodilation |
| 08/21/2008 | US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 08/21/2008 | US20080199445 Compositions and methods for treatment of microbial infections |
| 08/21/2008 | US20080199410 Pulmonary surfactant formulations and methods for promoting mucus clearance |
| 08/21/2008 | DE202007018403U1 Lutschtablette Lozenge |
| 08/21/2008 | DE102007007318A1 Coating composition for bioactive textile materials, useful e.g. for producing wound dressings, comprises layer-forming inorganic nanoparticulate sol and active component, e.g. natural oil |
| 08/21/2008 | CA2678072A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2677748A1 Binding members for ige molecules |
| 08/21/2008 | CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2676581A1 Heterocyclic derivatives as m3 muscarinic receptors |
| 08/20/2008 | EP1957537A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 08/20/2008 | EP1957516A2 Alfa-helix mimetics and method relating to the treatment of cancer stem cells |
| 08/20/2008 | EP1957483A1 Novel vinylogous acids derivatives |
| 08/20/2008 | EP1957471A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as 2 adrenoceptor agonists |
| 08/20/2008 | EP1957451A1 Soft anticholinergic zwitterions |
| 08/20/2008 | EP1957072A1 Treatment of asthma and copd using triple-combination therapy |
| 08/20/2008 | EP1957071A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 08/20/2008 | EP1957070A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 08/20/2008 | EP1663270B1 Method for the production of ivy leaf extracts, and extract produced according to said method |
| 08/20/2008 | EP1509618B1 Autoimmune conditions and nadph oxidase defects |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1446500B1 A method for regulating immune function in primates using the foxp3 protein |
| 08/20/2008 | EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | EP0703897B1 Lipoxin compounds with prolonged half-life |
| 08/20/2008 | CN101248174A Attenuated SARS and use as a vaccine |
| 08/20/2008 | CN101248077A P38 MAP kinase inhibitors and methods for using the same |
| 08/20/2008 | CN101248065A Activator of peroxisome proliferator activated receptor delta |
| 08/20/2008 | CN101248036A Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine |
| 08/20/2008 | CN101244224A Therapeutic agent for respiration diseases |
| 08/20/2008 | CN101244223A Chinese traditional medicine for curing asthma |
| 08/20/2008 | CN101244199A Chinese medicine pill for treating bronchial asthma, chronic bronchitis |
| 08/20/2008 | CN101244193A Traditional Chinese medicine for treating respiratory disease and method for preparing the same |
| 08/20/2008 | CN101244171A Externally used paste for treating cough, asthma and preparation thereof |
| 08/20/2008 | CN101244170A Medicament for treating children's exogenous cough and preparation method |
| 08/20/2008 | CN101244161A Method of preparing Chinese medicine for treating children's bronchopneumonia |
| 08/20/2008 | CN101244137A Medicament for treating pulmonitis, and high fever, lower fever non-reduction, and formulating method |
| 08/20/2008 | CN101244120A Method for preparing sianchau particle medicinal granules with multiple health care functions |
| 08/20/2008 | CN101244101A Chinese medicine composition for curing rhinitis |
| 08/20/2008 | CN101244072A Application of asiaticoside in pulmonary fibrosis resistant delayed period |
| 08/20/2008 | CN101244063A Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
| 08/20/2008 | CN101244050A Application of combination with a plurality of components in medicaments for tuberculosis and white plague |
| 08/20/2008 | CN101244049A Clenbuterol hydrochloride double-layer sustained release tablets and preparation thereof |
| 08/20/2008 | CN101243867A Pharynx clearing and throat benefiting soymilk powder and preparation thereof |
| 08/20/2008 | CN101243866A Instant throat-moistening tea and preparation thereof |
| 08/20/2008 | CN101243846A Corn chips relieving inflammation |
| 08/20/2008 | CN101243825A Inflammation relieving chewing gum |
| 08/20/2008 | CN101243819A Method for preparing Jupu tea |
| 08/20/2008 | CN101243812A Pharynx-clearing throat-benefiting dry milk and preparation thereof |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100411682C Medicament for treating chronic bronchitis and preparation method thereof |
| 08/20/2008 | CN100411664C Preparation method of medicine for treating nasopharynx inflam mation |
| 08/20/2008 | CN100411644C Medicine for treating chronic pharyngitis |
| 08/20/2008 | CN100411643C Composition of Chinese traditional medicine for curing cough and asthma, and preparation method |
| 08/20/2008 | CN100411617C Use of flavone compounds in preparing medicament |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414079 Alkyl alicyclic ethers, e.g., isopulegyl methyl ether, as a eucalptol replacement having a better flavor in oral care products for the mouth, throat and airways to produce a refreshing and clearing feelinga ; foods, tobacco product, candy, dentifrices; mouthwashes and pharmaceuticals |
| 08/19/2008 | US7414026 Inhibitors of NF-kappaB activation |
| 08/19/2008 | US7414022 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/14/2008 | WO2008098196A1 Treprostinil treatment for interstitial lung disease and asthma |
| 08/14/2008 | WO2008097676A1 Compounds and compositions as channel activating protease inhibitors |
| 08/14/2008 | WO2008097673A1 Compounds and compositions as channel activating protease inhibitors |
| 08/14/2008 | WO2008096870A1 Aza-bridged-ring compound |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof |
| 08/14/2008 | WO2008096730A1 Anti-inflammatory agent and use thereof |
| 08/14/2008 | WO2008096149A2 Napadisylate salt of a muscarinic m3 antagonist |
| 08/14/2008 | WO2008096143A1 Napadisylate salt of a muscarinic m3 antagonist |
| 08/14/2008 | WO2008096136A1 Combinations with a muscarinic receptor antagonist |